KEYNOTE: Submitting the eCTD to European Member States: Functionality, Processes, and Optimal Timelines for Regionally Wide Acceptance Andrew P Marr, Director, e-Regulatory Development, Global Regulatory Operations, GLAXOSMITHKLINE
FEATURED PRESENTATIONS: Moving from Data to Documents: The Next Stage for Global Submission Standards? Donald Palmer, Associate Director, Regulatory Systems, MEDIMMUNE
Reviewing eCTD Timelines with a Focus on Effeciency and Capturing Current Metrics for Future Submission Opportunities S. Albert Edwards, PharmD, RAC, Director, Regulatory Operations, TAKEDA GLOBAL RESEARCH & DEVELOPMENT CENTER